Stevanato Group S.p.A. (STVN)
NYSE: STVN · IEX Real-Time Price · USD
20.71
-0.20 (-0.96%)
May 17, 2024, 4:00 PM EDT - Market closed
Stevanato Group Revenue
Stevanato Group had revenue of $1.18B in the twelve months ending March 31, 2024, with 7.31% growth year-over-year. Revenue in the quarter ending March 31, 2024 was $256.52M, a -0.84% decrease year-over-year. In the year 2023, Stevanato Group had annual revenue of $1.21B with 15.24% growth.
Revenue (ttm)
$1.18B
Revenue Growth
+7.31%
P/S Ratio
4.81
Revenue / Employee
$209,010
Employees
5,634
Market Cap
5.67B USD
Revenue Chart
* The company reports in EUR currency but revenue data is shown in USD.
Revenue History
Fiscal Year End | Revenue | Change | Growth |
---|---|---|---|
Dec 31, 2023 | 1.21B | 159.48M | 15.24% |
Dec 31, 2022 | 1.05B | 87.47M | 9.12% |
Dec 31, 2021 | 959.00M | 151.64M | 18.78% |
Dec 31, 2020 | 807.36M | 204.51M | 33.92% |
Dec 31, 2019 | 602.85M | - | - |
Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
Company Name | Revenue |
---|---|
Organon & Co. | 6.35B |
DENTSPLY SIRONA | 3.94B |
Acadia Healthcare Company | 2.99B |
Exelixis | 1.85B |
Lantheus Holdings | 1.37B |
Halozyme Therapeutics | 862.99M |
Glaukos | 326.43M |
BridgeBio Pharma | 218.60M |
STVN News
- 19 hours ago - Stevanato Being Investigated on Behalf of Stevanato Group S.p.A. Investors. - Accesswire
- 9 days ago - Stevanato Group Reports Financial Results for the First Quarter of 2024 - Business Wire
- 16 days ago - Stevanato Group to Present at the Bank of America Securities Healthcare Conference - Business Wire
- 22 days ago - Stevanato Group to Report First Quarter 2024 Financial Results on May 9, 2024 - Business Wire
- 7 weeks ago - Stevanato Group Announces Closing of Upsized Public Offering of Ordinary Shares and Exercise in Full of the Underwriters' Option to Purchase Additional Ordinary Shares - Business Wire
- 2 months ago - Stevanato Group Announces Pricing of Upsized Public Offering of Ordinary Shares - Business Wire
- 2 months ago - Stevanato Group Announces Public Offering of Ordinary Shares - Business Wire
- 2 months ago - Stevanato Group to Present at the KeyBanc Capital Markets Virtual Life Sciences & MedTech Investor Forum - Business Wire